Drugs / recombinant influenza hemagglutinin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02335164 | Jul 2015 → Dec 2017 | avian influenza | Vaxine Pty Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant influenza hemagglutinin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02335164 ↗ |
| Modality | Vaccine | “pandemic avian H5 Influenza Vaccine” NCT02335164 ↗ |
| Route | Intramuscular | “administered by intramuscular injection” NCT02335164 ↗ |